The Singh lab at Georgia Institute of Technology (Georgia Tech) seeks a highly motivated Ph.D. professional for a postdoc position at the interface of immunology, biomaterials, and cancer technologies. We are considering applicants with a PhD degree with experience in standard and specialized laboratory skills from a wide range of areas, including but not limited to biomaterials, cell and tissue engineering, drug discovery and delivery, immunology, microfluidics, cell signaling, cancer biology, and epigenetics. Manuscript writing and presentations in meetings will be required.
The postdoctoral fellow will be compensated at or above NIH guidelines. Georgia Tech offers a comprehensive benefits package designed to meet the diverse needs of our employees (https://ohr.gatech.edu/benefits). Interested candidates should email a CV, two papers, and a short cover letter to Prof. Ankur Singh at email@example.com. The Postdoc will have the opportunity to work closely with collaborators at Georgia Tech, Emory Medicine and Emory Immunology, and continuing collaborations with Cornell University and Weill Cornell Medicine in New York City.
Multiscale engineering of lymphoid organs for infectious diseases and cancer: Our interest is in developing ex vivo immune organoids and on-chip technologies to:
1) Understand the process through which the B and T cells interact in the immune system to makes antibodies. We are interested in multiscale engineering strategies for the design and development of B and T cell-based immunotherapies. The engineered ex vivo immune organs have applications in immunity, cancer, infections, and inflammation.
2) Understand how disruption of normal signaling and epigenetic processes results in the transformation of healthy cells to cancers. By developing ex vivo “malignant” immune tissues in a dish or on-chip that represents human lymphomas, we aim to discover and advance new classes of signaling, epigenetic, and immune therapeutics.
About us: The “Immunotherapy and Cell Engineering Laboratory” is located in the Parker H. Petit Institute for Bioengineering & Bioscience (IBB), a hub for interdisciplinary research. The Petit Institute serves as the hub of several core facilities, which are available to affiliated labs at a highly subsidized rate. Details could be found here. https://petitinstitute.gatech.edu/research/core-facilities. The lab has published in leading journals, including Nature Methods, Nature Materials, Nature Communications, Nature Reviews Materials, Science Advances, PNAS, Cell Reports, Blood, Science Translational Medicine, Nature Protocols, Advanced Materials, Advanced Functional Materials, and Biomaterials.
Georgia Tech is an Affirmative Action/Equal Opportunity Employer.
Ankur Singh, Ph.D.